News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Eric K. Singhi: FDA Oncology approves amivantamab and chemo for EGFR and NSCLC
Photo of Eric K. Singhi from mdanderson.org
Oct 5, 2024, 02:12

Eric K. Singhi: FDA Oncology approves amivantamab and chemo for EGFR and NSCLC

Eric K. Singhi shared a post on X:

“FDA Oncology approves amivantamab and chemo for EGFR+ mNSCLC after TKI progression per phase 3 MARIPOSA-2 study:

    •  PFS: 6.3 v 4.2 mos (HR 0.48)
    •  ORR: 53% v 29%
    • No OS difference at interim (HR 0.73)
    • AEs: rash, IRR, nail toxicity, stomatitis.”

Source: Eric K. Singhi/X

Dr. Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.

Amivantamab cancer Eric K. Singhi FDA Oncology MARIPOSA-2 study MD Anderson Cancer Center NSCLC OncoDaily Oncology
Special Coverage
Insight
Jan 20, 2025, 16:23
Michelle Kirschner: Exciting Update from the Cancer Survivorship Provider Network
Insight
Jan 20, 2025, 16:23
Maryam Lustberg: The population of patients with advanced cancer is understudied and growing
Insight
Jan 20, 2025, 16:15
Group medical visits in cancer survivorship care - Journal of Cancer Survivorship
Stories
Jan 20, 2025, 16:15
Captain Matthew Walker's Battle with Cancer and the Importance of Health in the Fire Service
Insight
Jan 20, 2025, 16:15
Humaid Al-Shamsi: Delighted to welcome Saladin Sawan to Burjeel Cancer Institute
Insight
Jan 20, 2025, 16:07
The AACR Hematologic Malignancies Research Fellowship
Science
Jan 20, 2025, 16:03
Amy Moore: Biomarker testing can help identify actionable mutations in patients with squamous NSCLC
Insight
Jan 20, 2025, 16:03
Navneet Singh: Ensuring global access to the 3 'A's of treatment
Blog
Jan 20, 2025, 15:56
Erman Akkus: Downstaging of HCC before liver transplantation
Blog
Jan 20, 2025, 15:45
Chris Weight: Accepting applications for the Cleveland Clinic Urology, Society of Urologic Oncology fellowship program
Blog
Jan 20, 2025, 15:41
Endoscopic Ultrasound Gastroenterostomy versus Duodenal Stenting for Malignant GOO
Science
Jan 20, 2025, 15:25
Tony Hung: A virtual integrative medicine program to improve symptoms and decrease hospitalization